Results 211 to 220 of about 115,167,710 (246)
FDA 2025 Cancer Drug Approvals: targeted therapy dominates. [PDF]
Jørgensen JT.
europepmc +1 more source
An ultrasound‐activatable piezoelectric hydrogel reprograms chondrocyte mitochondrial epigenetics via the mTOR/GATD3A axis, clearing damaged mitochondria and alleviating osteoarthritis progression in both mouse models and human cartilage explants. ABSTRACT The avascular nature of cartilage hinders drug delivery for osteoarthritis (OA) therapy.
Hui Zheng +9 more
wiley +1 more source
A rapid, sensitive, and field-deployable RAA-EsCas13d platform for detection of porcine adenovirus type 3. [PDF]
Li Y-y +8 more
europepmc +1 more source
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib +8 more
wiley +1 more source
Identification of <i>EGFR</i>, <i>MMP9</i>, and <i>AGTR1</i> as actionable therapeutic targets in acetyl tributyl citrate-driven breast cancer: integrated network toxicology and <i>in vitro</i> validation. [PDF]
Zhou B, Zhou L, Zhang Y, An X.
europepmc +1 more source
We report the fast generation of biocompatible solutions of highly 13C‐hyperpolarized (≈11%) partially‐deuterated ketoisocaproate within <6 min using spin‐lock‐induced crossing and reversible exchange with parahydrogen (SLIC‐SABRE). This enables rapid detection of branched‐chain‐amino‐acid transferase 1 (BCAT1) protein expression and investigation of ...
Stefan Petersen +18 more
wiley +1 more source
Organ-on-a-chip platforms for disease modeling and in vitro diagnostic applications. [PDF]
Hao P, Deng J, Xu J.
europepmc +1 more source
ITGAX is associated with poor prognosis and an immune-inflammatory microenvironment in clear cell renal cell carcinoma. [PDF]
Chen X +6 more
europepmc +1 more source

